Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :673
Small font sizeDefault font sizeIncrease font size
Navigate Here
     My Preferences 
     Manuscript submission

 


This article has been cited by
1Efficacy and safety of proposed bevacizumab biosimilar BE1040V in patients with metastatic colorectal cancer: A phase III, randomized, double-blind, noninferiority clinical trial
Hamid Rezvani,Seyed Mohammadreza Mortazavizadeh,Abolghasem Allahyari,Amirabbas Nekuee,Safa Najjar Najafi,Mohammadreza Vahidfar,Mojtaba Ghadyani,Adnan Khosravi,Siroos Qarib,Alireza Sadeghi,Mohsen Esfandbod,Mohsen Rajaeinejad,Alireza Rezvani,Ali Hajiqolami,Mehrdad Payandeh,Babak Shazad,Nassim Anjidani,Shahab Meskinimood,Afsaneh Alikhasi,Moein Karbalaeian,Sina Salari
Clinical Therapeutics.2020;()
[DOI]
2Efficacy and safety of proposed bevacizumab biosimilar BE1040V in patients with metastatic colorectal cancer: A phase III, randomized, double-blind, noninferiority clinical trial
Sipan Keshishyan,Henry L. Nguyen,Olawale D. Afolabi,Carmen Moore,Adrienne T. Black,Sidhartha D. Ray
Clinical Therapeutics.2018;40()569
[DOI]
3Efficacy and Safety of Anti-cancer Biosimilars Compared to Reference Biologics in Oncology: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Jichun Yang,Shuqing Yu,Zhirong Yang,Yusong Yan,Yao Chen,Hongmei Zeng,Fei Ma,Yanxia Shi,Yehui Shi,Zilu Zhang,Feng Sun
BioDrugs.2019;33(4)357
[DOI]
  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow